PUT - SPRINTER OPEN END - ROCHE GS Share Price

Certificat

DE000VX9HEW7

Market Closed - Deutsche Boerse AG 11:13:52 24/05/2024 pm IST
16.8 EUR +0.42% Intraday chart for PUT - SPRINTER OPEN END - ROCHE GS
Current month-6.72%
1 month-6.25%
Date Price Change
24/24/24 16.8 +0.42%
23/24/23 16.73 +0.24%
22/24/22 16.69 +1.52%
21/24/21 16.44 +1.54%
17/24/17 16.19 -1.94%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 11:13 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VX9HEW
ISINDE000VX9HEW7
Date issued 04/04/2022
Strike 397.4 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 6.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 19.78
Lowest since issue 3.79

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
230.4 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.46%
Consensus